The 11,000-Year-Old Dog Cancer

Oliver Hart

Episode 3: "The 11,000-Year-Old Dog Cancer" The contagious cancer that used to be a dog — and the other cancers that learned to spread

HOST

Eleven thousand years ago — give or take a few thousand, we'll come back to that — a dog lies down near a human campfire, somewhere in northern Asia. It's a good dog. Medium-sized, wolfish, a little inbred if we're honest, the way early dogs were. It lives its dog life: it eats, it mates, it guards the fire. And then, like every dog before and since, it dies. Except. Somewhere in that dog's body, a single cell had made a copy error. A tumor — on the genitals, most likely, because that detail matters for what happens next. And when this dog mated, some of those tumor cells did something no cancer cell is supposed to do. They got off. They colonized another dog. And they kept going. Dog to dog to dog, down through the centuries — past the invention of writing, past the pyramids going up, past the rise and fall of every empire you've ever heard of.

HOST

That dog has been dead for millennia. Its cells are alive right now, in dogs on every continent except Antarctica. Today on The Odd Branch: the cancer that became a contagious, immortal... something. And the uncomfortable question of what to call it — because it may not be a dog anymore.

HOST

Welcome back to The Odd Branch, the show about the strange twigs on the tree of life. I'm your host, Dr. Ketchup. Today's rule is one of the most comforting facts in all of medicine: you cannot catch cancer. Cancer is your own cells turning against you — a civil war, not an invasion. It's not a cold. You can't get it from a sneeze, a handshake, or a sneezing handshake. And that rule is true. For humans. Almost always. We'll do the asterisks later. But in nature, there are a handful of cancers that broke the rule — cancers that became transmissible, jumping from body to body like a virus, except the infectious agent isn't a virus. It's living cancer cells. Someone else's cancer, moving in. Today: the three known flavors of contagious cancer. A dog cancer older than agriculture. A Tasmanian devil cancer that nearly ate a species. And a clam leukemia that swims through the ocean and — this is the part that gets me — crosses between species. Let's start with the old one. ACT 1 — THE DETECTIVE STORY

HOST

The dog cancer has a name: canine transmissible venereal tumor, or CTVT. And it's been hiding in plain sight for a long time. It was first described scientifically in 1876, by a Russian veterinarian named Novinsky, who did the obvious-in-hindsight experiment: he took tumor tissue from one dog, put it in another dog, and watched a tumor grow. Transmissible. Proven. In 1876. For decades, everyone assumed a virus must be responsible — because that's how transmissible tumors usually work; a virus causes the cancer, and it's the virus that spreads. But CTVT turned out to be something much stranger. The thing that spreads is not a virus that causes cancer. The thing that spreads is the cancer. The tumor cells themselves are the infectious agent. Every CTVT tumor, in every dog, everywhere, is a clone — a direct cellular descendant of that one ancient dog's tumor. Which means that when a vet anywhere in the world biopsies a CTVT tumor and sequences its DNA, they are not reading their patient's genome. They're reading the genome of a dog that died thousands of years ago. The tumor is a living fossil. And in 2014, scientists did exactly that — sequenced the whole genome — and the details they pulled out are where this story goes from creepy to astonishing. They could date it. By counting mutations, they estimated the founder dog lived around eleven thousand years ago — though I promised you honesty, so: a later, larger analysis put it more like four to eight and a half thousand years ago. The exact number is still being argued about, but either way, we're talking about a cell line older than the Great Pyramid. Older than Stonehenge. Possibly older than farming in most of the world. They could describe the dog. The genome says it was medium-to-large, wolf-like, and inbred — the kind of dog that lived alongside some of the earliest farming or hunter-gatherer communities in northern Asia. We will never know its name. But we have its genome, still walking around, still being copied, in millions of dogs. And they could count the scars. The tumor genome carries on the order of two million mutations — an absurd number that would kill almost any cell lineage. This thing has been copying itself, imperfectly, for thousands of years, and it just... keeps going. It's less a tumor than a dynasty.

HOST

One more historical detail, because it's too good. For most of its existence, this cancer stayed regional. Then, roughly five hundred years ago, it went global — and the genetic record shows it traveled along human sea routes. This ancient dog's cells crossed the oceans the way everything did back then: in the age of sail. The conquistadors brought horses, smallpox, and — accidentally — an immortal dog tumor. History is full of stowaways. ACT 2 — HOW A CANCER BECOMES IMMORTAL

HOST

Okay. So how does this possibly work? Your immune system is ferociously good at spotting foreign tissue — it's why organ transplants need a lifetime of immunosuppressant drugs. A cell from another dog should set off every alarm in the building. How does CTVT waltz in? Two tricks, and they're both elegant in the worst way. Trick one: it goes dark. Your immune system finds foreign cells by reading molecular ID cards on their surface — proteins called MHC molecules. CTVT cells simply... stop displaying them. They take down their own ID cards. No card, no check, no alarm. The cancer walks past the bouncer wearing an invisibility cloak made of missing paperwork. Trick two: it sedates the neighborhood. CTVT cells secrete signaling molecules — one called TGF-beta is a prime suspect — that actively suppress the local immune response. It's not just hiding; it's drugging the guards. But here's the twist that makes CTVT different from every horror story: it usually loses. In a healthy adult dog, the immune system typically figures it out within a few months. The ID cards come back, the alarms go off, and the tumor regresses — the dog's body destroys the invader and keeps a memory of it. Most dogs that get CTVT cure themselves. And for the cases that don't, this cancer is exquisitely sensitive to chemotherapy — a few doses of a common, cheap drug, and it's gone. It is, weirdly, one of the most curable cancers known. Think about that from the cancer's perspective. Over thousands of years, CTVT has evolved to be survivable — because a cancer that kills its host kills its own ride. The ancient dog's cells have mellowed into something closer to a parasite with good manners: they take what they need, they spread when they can, and they almost never burn the house down. It's the same lesson the tongue-eating isopod taught us last episode. The most successful invaders are the ones you can live with.

HOST

Now, the "oldest organism" claim, because the headlines love it and we should be precise. Is CTVT the oldest living thing on Earth? No — there are clonal plants and fungi that may be far older; there's a quaking aspen colony in Utah that's been cloning itself for possibly tens of thousands of years. But here's what CTVT legitimately is: the oldest known continuously living animal cell lineage. Every other animal cell dies with its body. These didn't. The closest human equivalent is HeLa — the famous cell line taken from Henrietta Lacks's cervical cancer in 1951, which has been growing in labs ever since, by the ton, powering decades of biomedical research. HeLa is seventy-some years old and exists because we keep it alive in incubators. CTVT has been doing the same trick for thousands of years, in the wild, with no lab, no incubator, no consent forms. Nature beat us to immortal cell lines by about eleven millennia. ACT 3 — THE OTHERS

HOST

CTVT is the old master, but it's not alone. There are two other places where cancer learned to spread — and each one teaches us something different. First: the Tasmanian devil. In 1996, a photographer in northeast Tasmania snapped a devil with strange tumors on its face. This was the first sighting of devil facial tumor disease — a transmissible cancer spread by biting. And devils bite a lot — it's how they fight, how they flirt, how they sort out who's in charge. The cancer cells physically transfer in the wounds and take root on the new devil's face. And this one is nothing like the polite dog cancer. Devil facial tumor disease is almost one hundred percent fatal. Since it appeared, devil populations have crashed — declines on the order of three-quarters of the species. An entire animal, pushed toward endangerment, by another animal's cancer. Two details here are worth your time. First, the transmission has a dark irony: researchers found that the devils most likely to get infected aren't the ones getting bitten — they're the dominant devils doing the biting. The cancer flows toward the aggressor. Second: in 2014, scientists found a second, independent transmissible face cancer in devils. DFT2. Meaning this didn't just happen once, in one unlucky species — it happened twice, in the same species, within a few decades. Which suggests that given the right conditions — biting behavior plus low genetic diversity, and devils are famously inbred — transmissible cancer isn't a freak accident. It's a niche, waiting to be filled. The good news, and there is some: devils are fighting back. Some wild devils now mount immune responses; the disease is showing signs of settling into an endemic, less apocalyptic state; and vaccine efforts — including oral bait vaccines, the same strategy that beat rabies in foxes — are in development. Evolution, meet conservation biology. It's a race, and both sides are running.

HOST

And then there are the clams. Soft-shell clams get a leukemia-like cancer — their blood cells proliferate out of control. For decades, nobody thought much of it. Then, in 2015, researchers sequenced the cancer cells from clams collected along the Atlantic coast and found something impossible: the cancers in different clams, from different beaches, were genetically identical to each other — and not identical to the clams carrying them. The cancer was spreading clam to clam. Through the water. Free cancer cells, released by sick clams, drifting in the sea and infecting healthy ones. It gets better. Or worse, depending on your relationship with the ocean. Follow-up work found these transmissible cancers in mussels, in cockles, in multiple clam species — and found cases where the cancer in one species genetically matched a different species entirely. The cancer had jumped the species barrier. A cancer that started in one kind of clam is now living in another kind of clam, in another sea. And a 2024 study found these cancers cluster around ports and urbanized coastlines — our harbors are hubs in a cancer's shipping network. So let's tally the ocean's achievement: cancer that swims, cancer that crosses species, and cancer that has evolved this trick independently, multiple times, in multiple bivalve lineages. The sea has been running this experiment over and over, and it keeps working. Why don't we see this everywhere? Because of the ID-card system. Mammals have ferociously diverse MHC molecules — that's exactly why transplants are hard — and that diversity is a wall most cancers can't climb. Devils are inbred enough that the wall has gaps. Clams barely have a wall. And CTVT is the one that learned to pick the lock. The exceptions don't break the rule. They show you exactly where the rule comes from. THE INTERNET LIED TO YOU

HOST

Time for The Internet Lied to You — and this week's lie is the scary one you might be quietly thinking: so can I catch cancer? No. You cannot catch cancer from another person. Not from touch, not from kissing, not from sharing a drink, not from a sneeze. There is no known naturally circulating transmissible cancer in humans, full stop. The asterisks are medical and rare. Cancer cells have occasionally passed through organ transplants from donors with undiagnosed cancers — which is why donor screening exists. In extraordinarily rare cases, a pregnant mother's cancer has crossed the placenta to the fetus. And then there's my favorite terrible case report in all of medicine: a man with a severely compromised immune system who developed tumors that turned out, on sequencing, to contain tapeworm DNA. His tapeworm got cancer, and the tapeworm's cancer spread to him. He did not catch cancer. He caught a cancer from his parasite. There is always a weirder sentence waiting in the medical literature. But the everyday fear — that cancer is contagious like a cold — is false. The dog cancer needed eleven thousand years, a venereal transmission route, and an invisibility cloak made of missing ID cards. You are safe from your friends. ACT 4 — WHAT DO YOU CALL A DOG THAT ISN'T A DOG?

HOST

Let's end where this show always ends: at the boundary. Episode one asked whether your behavior is yours. Episode two asked whether your organs are yours. This episode asks the strangest version yet: can your cells stop being you... and become someone else? Because that's what happened. Eleven thousand years ago, give or take, a cell in a dog stopped obeying the dog. And then it did something no cell is supposed to do: it outlived its body, moved into new bodies, and kept going. It has its own genome now — the dog's genome, plus thousands of years of accumulated edits. It has its own ecology — it lives on dogs, the way the tongue isopod lives on fish. It has its own evolutionary trajectory — it has adapted, mellowed, learned to hide from immune systems and to keep its hosts alive. It reproduces. It disperses. It evolves. So what is it? A tumor? Tumors die with their hosts; this one has outlived its host by millennia. A dog? It has a dog's genome, but it has never once fetched a stick. A parasite? It's made of dog. A new species? Some scientists have floated exactly that — half-seriously, which in biology is how most serious ideas start. There's no clean answer, and I love that, because it means the categories are the problem, not the cancer. We file life into "individuals" and "species" and "diseases," and then something like CTVT comes along — a dog that became a disease that became, arguably, an organism — and the filing system just shrugs. And here's the part I keep coming back to. That ancient dog by the campfire achieved a kind of immortality that no pharaoh managed. Not as a memory. Not as bones in a museum. As living, dividing, traveling cells — still here, still going, carried by the descendants of the very animals it lived beside. It is the worst possible way to live forever, and it worked.

HOST

The self, it turns out, is not a fortress. It's a border town. Things cross.

HOST

That's it for Episode 3 of The Odd Branch. If you enjoyed finding out that the oldest dog alive is technically a cancer, subscribe wherever you get your podcasts, and tell a friend. Not your dog, though. Some things they don't need to know. Next time, the jellyfish that hits rewind. When Turritopsis dohrnii gets old, sick, or injured, it doesn't die — it collapses back into a polyp and starts its life over. Biological immortality, round two — and this one isn't a cancer. It's the whole animal. Sources are in the show notes, including the ongoing argument about exactly how old the dog cancer is. I'm Dr. Ketchup. Stay curious. Stay odd.